Honduras mandates face masks again as respiratory illnesses spike
TEGUCIGALPA (Reuters) -Over five years after the COVID-19 outbreak, Honduras has reinstated mandatory mask wearing in public spaces amid a spike in respiratory illnesses and as a variant of the virus spreads through the Central American country.
Honduras' health ministry confirmed two deaths from the virus this week, among patients with underlying health conditions, bringing the country's total in 2025 to six.
"We have already surpassed last year's infection limit; there are currently five people admitted to Hospital Escuela with suspected COVID-19," said the head of Health Surveillance, Lorenzo Pavon.
Official data showed that from January to July last year, 596 COVID-19 cases were reported, while this year 654 cases have been recorded in the same period.
The temporary measures, which took effect on Thursday, make masks obligatory in hospitals, airports, shopping centers, banks, schools, public transport, and other enclosed or crowded spaces. The government also ordered temporary work-from-home for state institutions.
Authorities are urging the public to complete their COVID-19 and influenza vaccination schedules and to seek medical advice for respiratory symptoms. Frequent hand washing and the use of antibacterial gel continue to be recommended measures.
Officials also warned that they will maintain monitoring of variants and will reinforce public information campaigns. The Ministry of Health reiterated that it will continuously evaluate the epidemiological situation and warned that the measures could be expanded if the number of infections continues to rise.
(Reporting by Joan Humberto Suazo; Writing by Raul Cortes and Natalia Siniawski; Editing by Aurora Ellis)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
5 hours ago
- The Star
Study: Covid-19 has affected our brains
The strain on people's lives during the pandemic such as weeks of isolation and uncertainty surrounding the crisis may have aged people's brains, researchers believe. — dpa The Covid-19 pandemic was 'detrimental' to brain health, even among people who never caught the infection, a new study reveals. Academics suggest the strain on people's lives – from isolation for weeks on end to the uncertainty surrounding the crisis – may have aged the brains of society. They found that brain ageing during the pandemic was 'more pronounced' among men, older people and people from deprived backgrounds. Brain ageing models were trained on more than 15,000 healthy people. These were then applied to almost 1,000 people taking part in the UK Biobank study – a long-term study tracking the health of middle and older aged adults. Half of the group had brain scans before the pandemic while the others had brain scans before and after the global crisis. After looking at the scans, academics said that the pandemic 'significantly' accelerated brain ageing. This was assessed by their brain age, as determined by the scans, compared with their actual age. The research team found that, on average, the scans taken after people had lived through the crisis had a '5.5-month higher deviation of brain age gap'. 'We found that the Covid-19 pandemic was detrimental to brain health and induced accelerated brain ageing. regardless of SARS-CoV-2 infection,' the experts from the University of Nottingham wrote in the journal Nature Communications . Dr Ali-Reza Mohammadi-Nejad, who led the study, said: 'What surprised me most was that even people who hadn't had Covid showed significant increases in brain ageing rates. 'It really shows how much the experience of the pandemic itself, everything from isolation to uncertainty, may have affected our brain health.' The research team also examined whether having Covid-19 affected someone's cognitive performance by examining the results of tests taken at the time of the scans. They found that people who were infected with the virus appeared to perform more poorly on cognitive tests when they were assessed again after the pandemic. Dr Dorothee Auer, professor of neuroimaging and senior author on the study, added: 'This study reminds us that brain health is shaped not only by illness, but by our everyday environment. 'The pandemic put a strain on people's lives, especially those already facing disadvantage. 'We can't yet test whether the changes we saw will reverse, but it's certainly possible, and that's an encouraging thought.' – PA Media/dpa
The Star
2 days ago
- The Star
Creative financing key to sustaining national healthcare, says Dzulkefly
PETALING JAYA: Bold, creative financing reforms are the only way forward to heal the deep cracks in Malaysia's healthcare system unmasked by the Covid-19 pandemic, says Health Minister Datuk Seri Dr Dzulkefly Ahmad (pic). Unveiling plans for public-private collaboration under a government-linked investment company (GLIC) model, he warned that health security must be treated with the same urgency as national defence. Dzulkefly said this yesterday at the launch of a book titled Crisis and Community: Covid-19 in Malaysia at Gerakbudaya here. On the concerns that the Health Ministry's Rakan KKM initiative is a form of healthcare privatisation, Dzulkefly said he will not reveal details but noted it was created due to budgetary allocation limits, national debt, and GDP ratios that restrict spending. He said health security must be dealt with 'the same urgency we defend our borders'. 'That means sustained investment in our healthcare workforce. 'I am introducing a game-changing initiative where public facilities collaborate with private sector specialists, likely under a GLIC model. 'The idea is to generate revenue through elective services (non-emergency), possibly in specialised private wings within public hospitals. 'Funds generated would cross-subsidise public health services and infrastructure,' said Dzulkefly. 'We want to retain our specialists, reduce the bleeding, and invest back into public facilities. 'I can't keep asking for more budget, so I'm unlocking value through reforms,' said Dzulkefly. He also said the Covid-19 had shown that the healthcare system has inadequate social safety nets for vulnerable groups such as the elderly and the mentally ill. 'Future crisis governance must be targeted, empathetic, data-informed and inclusive. 'We must design interventions that are community-driven and flexible, not one-size-fits-all,' said Dzulkefly. At the forum, consultant paediatrician and child disability activist Datuk Dr Amar-Singh HSS said that Covid-19 has revealed the fragility of our institutional services. 'During the height of the pandemic, we experienced desperate cries for help to find an ICU bed for their family members. 'The support for carers was weak, and equipment and resources were limited even in non-pandemic times, stretched thin. 'Some doctors placed their children with grandparents and did not see them for months,' said Dr Amar. He said that there must be better preparation for the next pandemic by placing greater emphasis on building our institutional services, especially health, education and social services. He also urged making indoor air more clean, as he said most indoor air is filled with 'airborne diseases'. Ampang Hospital paediatrician Dr Tan Hui Siu narrated how medical officers and healthcare workers trudged the pandemic and had to make do with what they had as frontliners. Virologist and policy analyst Dr Lyana Khairuddin called for better education on the vaccine naysayers as well as more investments be made into vaccine research and development.
The Star
2 days ago
- The Star
Japan discards state-acquired Covid-19 drugs worth US$1.6bil
TOKYO: (Bernama-Kyodo) The Japanese government discarded Covid-19 oral medicines believed to be worth around 240 billion yen (US$1.6 billion) in the fiscal year through March as they had passed their expiry dates, Kyodo News Agency reported, citing health ministry officials on Wednesday (July 16). While the exact purchase price remains unclear, the value was calculated in accordance with current prices. The amount is enough to treat some 2.5 million people. The government acquired the oral drugs at the height of the coronavirus pandemic and provided them free of charge to hospitals and clinics nationwide. But many of them were unused after Covid-19 was downgraded to the same category as seasonal influenza in May 2023, which required people to pay for Covid-19 treatment. Drugmakers had also started general distribution of Covid-19 medicine in Japan themselves. A Ministry of Health, Labour and Welfare official said offering the drugs to other countries was considered but legally difficult. Among the two million doses of Pfizer Inc.'s nirmatrelvir and 1.6 million doses of Merck & Co.'s molnupiravir procured by the government, about 1.75 million doses of nirmatrelvir and some 780,000 doses of molnupiravir were disposed of, according to the ministry. The government also secured two million doses of Shionogi & Co.'s ensitrelvir but about 1.77 million of them are unused, the ministry said. They are expected to be discarded after they reach their expiration dates starting next fiscal year. - Bernama-Kyodo
